Source Newsroom: Endocrine Society
Newswise — The Hormone Foundation, the public education affiliate of The Endocrine Society, can provide medical experts for interviews and commentary regarding the risks and benefits of hormone therapy during National Menopause Awareness Month.
In addition, new resources created by the Foundation, in collaboration with the Center for Media and Public Affairs (www.cmpa.com) and the Statistical Assessment Service (www.stats.org) at George Mason University, can be found at http://www.hormone.org/Menopause/menopause_and_womens_health.cfm. These include: a content analysis of media coverage (2002 – 2007); a select literature review of menopause research; a bibliography of menopause research; and an FAQ reference document on some of the key questions around menopause trials.
Menopause represents the end of a women’s fertility. For most women, menopause is a natural part of aging that occurs at about age 51. For others, menopause can be brought on by a medical condition (such as premature ovarian failure) or by surgery or cancer treatment. Menopause is often accompanied by symptoms such as hot flashes, sleep disturbances and vaginal dryness, as well as long-term health risks such as osteoporosis and heart disease.
The most commonly used treatment for the relief of menopausal symptoms is hormone therapy (estrogen or estrogen plus progestin). Since the 2002 announcement of the Women’s Health Initiative (WHI) study – a major clinical trial designed to determine how diet, hormone therapy, and calcium and vitamin D might prevent heart disease, cancer, and bone fractures in women – there have been many questions about the benefits and risks of hormone therapy.
With millions of American women facing difficult questions about the best way to manage menopausal symptoms, The Hormone Foundation is committed to providing access to medical experts and resources on the Web.
The Hormone Foundation’s menopause program was supported by an educational grant from Wyeth Pharmaceuticals.
WHO: Hormone Foundation experts:
Nanette Santoro, MD – Director, Division of Reproductive Endocrinology and Infertility, Dept. of OB/GYN and Women’s Health, Albert Einstein College of Medicine; Bronx, NY.
S. Robert Lichter, PhD – President, The Center for Media and Public Affairs, George Mason University; Fairfax, VA
WHAT: Leading endocrinologists are available to discuss menopause and the risks and benefits of hormone therapy. Menopause information and resources for patients are also available on the Web at: www.hormone.org
About The Hormone Foundation
The Hormone Foundation is the public education affiliate of The Endocrine Society and is a leading source of hormone-related health information for the public, physicians, allied health professionals and the media. Their mission is to serve as a resource for the public by promoting the prevention, treatment and cure of hormone-related conditions through outreach and education. For more information about the Foundation, visit www.hormone.org
About The Endocrine Society
Founded in 1916, The Endocrine Society is the world’s oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, The Endocrine Society’s membership consists of more than 14,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology. The Endocrine Society is based in Chevy Chase, Maryland. To learn more about the Society and the field of endocrinology, visit our Web site at www.endo-society.org.